Therapeutic efficacy of macrolides in management of patients with mild COVID-19
Evidence on the efficacy of adding macrolides (azithromycin or clarithromycin) to the treatment regimen for COVID-19 is limited. We testify whether adding azithromycin or clarithromycin to a standard of care regimen was superior to standard of supportive
Alaa Rashad +9 more
doaj +1 more source
High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong [PDF]
Background: Metronidazole resistance is a common problem in most Asian countries, and clarithromycin has been widely used in Hong Kong. Aim: To determine the prevalence of Helicobacter pylori strains resistant to metronidazole and clarithromycin in Hong ...
Berg, DE +9 more
core +1 more source
Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results [PDF]
Aim. Determine the primary antibiotic resistance of Helicobacter pylori (H. pylori) strains isolated from patients living in the European part of the Russian Federation. Materials and methods. As part of a clinical laboratory study, from 2015 to 2018,
I. V. Maev +15 more
doaj +1 more source
Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutic options [PDF]
Infection and inflammation may have a crucial role in the pathogenesis of atherosclerosis. This hypothesis is supported by an increasing number of reports on the interaction between chronic infection, inflammation, and atherogenesis.
Abbas, M.A. +6 more
core +1 more source
Severe pertussis infection in infants less than 6 months of age: clinical manifestations and molecular characterization [PDF]
We conducted a study to determine the main traits of pertussis among unimmunized infants less than 6 months of age. From August 2012 to March 2015, 141 nasopharyngeal aspirates (NPAs) were collected from infants with respiratory symptoms attending 2
Buttinelli, Gabriele +12 more
core +1 more source
We encountered a case in which the general condition of a patient receiving cabazitaxel worsened with concomitant use of clarithromycin. Cabazitaxel is metabolized mainly by CYP3A4, and the frequency of adverse events is known to increase with increasing
Shigeaki Katsumi +5 more
doaj +1 more source
Infection With Mycobacterium chelonae Following Autologous Facial Fat Grafting: A Case Report and Review of Literature. [PDF]
ABSTRACT Background Autologous fat grafting is commonly used in cosmetic dermatology, but it can cause serious complications, including nontuberculous mycobacterial infections when done under unsterile conditions. Case Presentation We report a 39‐year‐old woman who developed multiple discharging facial abscesses 1 month after undergoing autologous fat ...
Alavi Darazam I +4 more
europepmc +2 more sources
Changes of Interleukins in Patients with Nosocomial Pneumonia Against a Background of Traumatic Brain Injury: Role in the Diagnosis and Monitoring of Disease [PDF]
Introduction. Nosocomial pneumonia (NP) is the second leading frequency and mortality among nosocomial infections. NP is a frequent complication of severe traumatic brain injury (TBI).
Ilchenko, A. (Anastasiia)
core +2 more sources
Different polylactic acid (PLA) thin films containing clarithromycin and a number of metal oxide nanoparticles (magnesium, titanium, zinc, and nickel) dioxides were created. Low dosages of metal oxides (0.01% by weight) and clarithromycin (0.5% by weight)
Hadeel Adil +8 more
doaj +1 more source
Background Clarithromycin-containing triple therapy is commonly used to treat Helicobacter pylori infections. Clarithromycin resistance is the leading cause of H. pylori treatment failure. Understanding the specific mutations that occur in H.
Naim Asyraf Rosli +5 more
doaj +1 more source

